GCA
BIIB icon

Greenwood Capital Associates’s Biogen BIIB Stock Holding History

Greenwood Capital Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,145
Closed -$4.95M – 252
2023
Q4 		$4.95M Buy
19,145
+65
+0.3% +$16K 0.64% 58
2023
Q3 		$4.9M Sell
19,080
-6,282
-25% -$1.68M 0.71% 51
2023
Q2 		$7.22M Sell
25,362
-2,841
-10% -$846K 1.01% 34
2023
Q1 		$7.84M Buy
28,203
+1,914
+7% +$530K 1.13% 28
2022
Q4 		$7.28M Sell
26,289
-552
-2% -$156K 1.19% 29
2022
Q3 		$7.17M Sell
26,841
-1,924
-7% -$409K 1.23% 28
2022
Q2 		$5.87M Buy
28,765
+3,039
+12% +$621K 0.94% 40
2022
Q1 		$5.42M Buy
+25,726
New +$5.59M 1.42% 22
2019
Q2 		– Sell
-18,102
Closed -$4.28M – 174
2019
Q1 		$4.28M Buy
18,102
+635
+4% +$200K 1.1% 37
2018
Q4 		$5.26M Buy
17,467
+1,878
+12% +$599K 1.38% 28
2018
Q3 		$5.51M Buy
15,589
+852
+6% +$293K 1.2% 36
2018
Q2 		$4.28M Buy
14,737
+3,359
+30% +$944K 0.99% 47
2018
Q1 		$3.12M Sell
11,378
-190
-2% -$59K 0.76% 58
2017
Q4 		$3.69M Sell
11,568
-7
-0.1% -$2.25K 0.86% 48
2017
Q3 		$3.62M Buy
+11,575
New +$3.43M 0.9% 46

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Greenwood Capital Associates's BIIB Position: Q1 2024 in Review

Greenwood Capital Associates sold out of Biogen (BIIB) in Q1 2024, closing a stake of 19,145 shares — an estimated $4.95M sold.

Greenwood Capital Associates first reported a position in BIIB in Q3 2017 and held it in 15 quarters. The position peaked at $7.84M in Q1 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Greenwood Capital Associates reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Greenwood Capital Associates sold 19,145 Biogen shares in Q1 2024, an estimated $4.95M.
  • Greenwood Capital Associates first reported a position in Biogen in Q3 2017 and held it in 15 quarters.
  • Greenwood Capital Associates's Biogen position peaked at $7.84M in Q1 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Greenwood Capital Associates's 13F filing for Q1 2024, filed 1 May 2024.